In the AIDS clinical trials group longitudinal linked randomized trials (ALLRT) cohort, a CD8 count >1500 cells/μL at year two of ART predicted a 75% increased risk of AIDS and non-infectious non-AIDS events during the following five years of treatment.13 The gene discussed is CD8A; the disease is AIDS.